Does SEMAGLUTIDE Cause Product use in unapproved indication? 2,613 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 2,613 reports of Product use in unapproved indication have been filed in association with SEMAGLUTIDE (WEGOVY). This represents 4.4% of all adverse event reports for SEMAGLUTIDE.
2,613
Reports of Product use in unapproved indication with SEMAGLUTIDE
4.4%
of all SEMAGLUTIDE reports
31
Deaths
440
Hospitalizations
How Dangerous Is Product use in unapproved indication From SEMAGLUTIDE?
Of the 2,613 reports, 31 (1.2%) resulted in death, 440 (16.8%) required hospitalization, and 57 (2.2%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SEMAGLUTIDE. However, 2,613 reports have been filed with the FAERS database.
What Other Side Effects Does SEMAGLUTIDE Cause?
Nausea (10,036)
Vomiting (6,518)
Off label use (5,425)
Diarrhoea (5,331)
Decreased appetite (4,317)
Constipation (4,036)
Weight decreased (3,518)
Impaired gastric emptying (2,622)
Wrong technique in product usage process (2,538)
Abdominal pain upper (2,503)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which SEMAGLUTIDE Alternatives Have Lower Product use in unapproved indication Risk?
SEMAGLUTIDE vs SEMUSTINE
SEMAGLUTIDE vs SENNA LEAF
SEMAGLUTIDE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SEMAGLUTIDE vs SENNOSIDES
SEMAGLUTIDE vs SENNOSIDES A AND B